SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

Pharmacyclics, Inc.
(NASDAQ : PCYC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading PCYC News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.10%125.021.0%$977.56m
PFEPfizer Inc.
0.05%36.732.0%$773.48m
MRKMerck & Co., Inc.
0.05%58.820.8%$529.08m
ABBVAbbVie, Inc.
-0.19%63.771.5%$503.92m
BMYBristol-Myers Squibb Company
0.23%75.671.5%$396.57m
LLYEli Lilly and Company
1.49%81.601.2%$360.12m
AZNAstraZeneca PLC Sponsored ADR
1.93%31.120.4%$212.03m
GSKGlaxoSmithKline plc Sponsored ADR
0.67%43.890.1%$169.66m
SNYSanofi Sponsored ADR
0.93%42.290.1%$151.46m
NVSNovartis AG Sponsored ADR
0.90%83.490.2%$128.16m
NVONovo Nordisk A/S Sponsored ADR Class B
1.07%55.610.3%$62.75m
LCILannett Company, Inc.
-0.46%30.6425.4%$26.88m
SCMPSucampo Pharmaceuticals, Inc. Class A
-1.72%11.417.0%$4.08m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.80%8.770.1%$0.05m
EPIXESSA Pharma Inc
-4.60%2.800.0%$0.02m

Company Profile

Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The company has three product candidates in clinical development and several preclinical molecules in lead optimization. Its clinical development and product candidates are small-molecule enzyme inhibitors designed to target key biochemical pathways involved in human diseases with critical unmet needs. Pharmacyclics was founded on April 19, 1991 and is headquartered in Sunnyvale, CA.